|31.50||+1.48 / +4.93%|
Data as of 3:59pm ET
|31.50||+0.0038 / +0.01%|
The 6 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 37.50, with a high estimate of 46.00 and a low estimate of 31.00. The median estimate represents a +19.05% increase from the last price of 31.50.
The current consensus among 6 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.